Plasmodium P25 and P28 surface proteins: Potential transmission-blocking vaccines

Eukaryotic Cell

Volumn 6, Issue 8, 2007, Pages 1260-1265

  Saxena, Ajay K ^a   Wu, Yimin ^b   Garboczi, David N ^b  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MALARIA VACCINE; OOKINETE ANTIGEN P25, PLASMODIUM; PARASITE ANTIGEN; PROTOZOAL PROTEIN; UNCLASSIFIED DRUG;

ANIMAL; ANOPHELES; DISEASE TRANSMISSION; DRUG EFFECT; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; MALARIA; PARASITOLOGY; PLASMODIUM; SHORT SURVEY;

ANIMALS; ANOPHELES; ANTIGENS, PROTOZOAN; MALARIA; MALARIA VACCINES; PLASMODIUM; PROTOZOAN PROTEINS;

EID: 34547865710     PISSN: 15359778     EISSN: None     Source Type: Journal    
DOI: 10.1128/EC.00060-07     Document Type: Short Survey

References (73)

1. Adini, A., and A. Warburg. 1999. Interaction of Plasmodium gallinaceum ookinetes and oocysts with extracellular matrix proteins. Parasitology 119: 331-336.
2. Appella, E., I. T. Weber, and F. Blasi. 1988. Structure and function of epidermal growth factor-like regions in proteins. FEBS Lett. 231:1-4.
3. Arrighi, R. B., and H. Hurd. 2002. The role of Plasmodium berghei ookinete proteins in binding to basal lamina components and transformation into oocysts. Int. J. Parasitol. 32:91-98.
4. Barr, P. J., K. M. Green, H. L. Gibson, I. C. Bathurst, I. A. Quakyi, and D. C. Kaslow. 1991. Recombinant Pfs25 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals. J. Exp. Med. 174:1203-1208.
5. Baton, L. A., and L. C. Ranford-Cartwright. 2005. Do malaria ookinete surface proteins P25 and P28 mediate parasite entry into mosquito midgut epithelial cells? Malar. J. 4:15.
6. Carter, R. 2001. Transmission blocking malaria vaccines. Vaccine 19:2309-2314.
7. Carter, R., P. M. Graves, D. B. Keister, and I. A. Quakyi. 1990. Properties of epitopes of Pfs 48/45, a target of transmission blocking monoclonal antibodies, on gametes of different isolates of Plasmodium falciparum. Parasite Immunol. 12:587-603.
8. Carter, R., P. M. Graves, I. A. Quakyi, and M. F. Good. 1989. Restricted or absent immune responses in human populations to Plasmodium falciparum gamete antigens that are targets of malaria transmission-blocking antibodies. J. Exp. Med. 169:135-147.
9. Coban, C., M. T. Philipp, J. E. Purcell, D. B. Keister, M. Okulate, D. S. Martin, and N. Kumar. 2004. Induction of Plasmodium falciparum transmission-blocking antibodies in nonhuman primates by a combination of DNA and protein immunizations. Infect. Immun. 72:253-259.
10. Danielli, A., C. Barillas-Mury, S. Kumar, F. C. Kafatos, and T. G. Loukeris. 2005. Overexpression and altered nucleocytoplasmic distribution of Anopheles ovalbumin-like SRPN10 serpins in Plasmodium-infected midgut cells. Cell. Microbiol. 7:181-190.
11. Danielli, A., F. C. Kafatos, and T. G. Loukeris. 2003. Cloning and characterization of four Anopheles gambiae serpin isoforms, differentially induced in the midgut by Plasmodium berghei invasion. J. Biol. Chem. 278:4184-4193.
12. Dessens, J. T., A. L. Beetsma, G. Dimopoulos, K. Wengelnik, A. Crisanti, F. C. Kafatos, and R. E. Sinden. 1999. CTRP is essential for mosquito infection by malaria ookinetes. EMBO J. 18:6221-6227.
13. Dessens, J. T., I. Siden-Kiamos, J. Mendoza, V. Mahairaki, E. Khater, D. Vlachou, X. J. Xu, F. C. Kafatos, C. Louis, G. Dimopoulos, and R. E. Sinden. 2003. SOAP, a novel malaria ookinete protein involved in mosquito midgut invasion and oocyst development. Mol. Microbiol. 49:319-329.
14. Duffy, P. E., and D. C. Kaslow. 1997. A novel malaria protein, Pfs28, and Pfs25 are genetically linked and synergistic as falciparum malaria transmission-blocking vaccines. Infect. Immun. 65:1109-1113.
15. Duffy, P. E., P. Pimenta, and D. C. Kaslow. 1993. Pgs28 belongs to a family of epidermal growth factor-like antigens that are targets of malaria transmission-blocking antibodies. J. Exp. Med. 177:505-510.
16. Gass, R. F., and R. A. Yeates. 1979. In vitro damage of cultured ookinetes of Plasmodium gallinaceum by digestive proteinases from susceptible Aedes aegypti. Acta Trop. 36:243-252.
17. Good, M. F., D. C. Kaslow, and L. H. Miller. 1998. Pathways and strategies for developing a malaria blood-stage vaccine. Annu. Rev. Immunol. 16:57-87.
18. Hafalla, J. C., M. L. Santiago, M. C. Pasay, B. L. Ramirez, M. M. Gozar, A. Saul, and D. C. Kaslow. 1997. Minimal variation in the Pfs28 ookinete antigen from Philippine field isolates of Plasmodium falciparum. Mol. Biochem. Parasitol. 87:97-99.
19. Han, Y. S., and C. Barillas-Mury. 2002. Implications of time bomb model of ookinete invasion of midgut cells. Insect Biochem. Mol. Biol. 32:1311-1316.
20. Han, Y. S., J. Thompson, F. C. Kafatos, and C. Barillas-Mury. 2000. Molecular interactions between Anopheles stephensi midgut cells and Plasmodium berghei: the time bomb theory of ookinete invasion of mosquitoes. EMBO J. 19:6030-6040.
21. Hisaeda, H., A. W. Stowers, T. Tsuboi, W. E. Collins, J. S. Sattabongkot, N. Suwanabun, M. Torii, and D. C. Kaslow. 2000. Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of Plasmodium vivax to infect mosquitoes. Infect. Immun. 68:6618-6623.
22. Janse, C. J., and A. P. Waters. 2004. Sexual development of malarial parasites, p. 445-474. In A. P. Waters and C. J. Janse (ed.), Malaria parasites, genomes, and molecular biology. Caister Academic Press, Wymondham, Norfolk, England.
23. Kadota, K., T. Ishino, T. Matsuyama, Y. Chinzei, and M. Yuda. 2004. Essential role of membrane-attack protein in malarial transmission to mosquito host. Proc. Natl. Acad. Sci. USA 101:16310-16315.
24. Kaslow, D. C. 1997. Transmission-blocking vaccines: uses and current status of development. Int. J. Parasitol. 27:183-189.
25. Kaslow, D. C. 2002. Transmission-blocking vaccines. Chem. Immunol. 80: 287-307.
26. Kaslow, D. C., I. C. Bathurst, T. Lensen, T. Ponnudurai, P. J. Barr, and D. B. Keister. 1994. Saccharomyces cerevisiae recombinant Pfs25 adsorbed to alum elicits antibodies that block transmission of Plasmodium falciparum. Infect. Immun. 62:5576-5580.
27. Kaslow, D. C., I. A. Quakyi, C. Syin, M. G. Raum, D. B. Keister, J. E. Coligan, T. F. McCutchan, and L. H. Miller. 1988. A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains. Nature 333:74-76.
28. Kaslow, D. C., C. Syin, T. F. McCutchan, and L. H. Miller. 1989. Comparison of the primary structure of the 25 kDa ookinete surface antigens of Plasmodium falciparum and Plasmodium gallinaceum reveals six conserved regions. Mol. Biochem. Parasitol. 33:283-287.
29. Kiszewski, A., A. Mellinger, A. Spielman, P. Malaney, S. E. Sachs, and J. Sachs. 2004. A global index representing the stability of malaria transmission. Am. J. Trop. Med. Hyg. 70:486-498.
30. Kotsyfakis, M., L. Ehret-Sabatier, I. Siden-Kiamos, J. Mendoza, R. E. Sinden, and C. Louis. 2005. Plasmodium berghei ookinetes bind to Anopheles gambiae and Drosophila melanogaster annexins. Mol. Microbiol. 57:171-179.
31. Kubler-Kielb, J., F. Majadly, Y. Wu, D. L. Narum, C. Guo, L. H. Miller, J. Shiloach, J. B. Robbins, and R. Schneerson. 2007. Long-lasting and transmission-blocking activity of antibodies to Plasmodium falciparum elicited in mice by protein conjugates of Pfs25. Proc. Natl. Acad. Sci. USA 104:293-298.
32. Kumar, N., and R. Carter. 1985. Biosynthesis of two stage-specific membrane proteins during transformation of Plasmodium gallinaceum zygotes into ookinetes. Mol. Biochem. Parasitol. 14:127-139.
33. Luckhart, S., Y. Vodovotz, L. Cui, and R. Rosenberg. 1998. The mosquito Anopheles stephensi limits malaria parasite development with inducible synthesis of nitric oxide. Proc. Natl. Acad. Sci. USA 95:5700-5705.
34. Malkin, E. M., A. P. Durbin, D. J. Diemert, J. Sattabongkot, Y. Wu, K. Miura, C. A. Long, L. Lambert, A. P. Miles, J. Wang, A. Stowers, L. H. Miller, and A. Saul. 2005. Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria. Vaccine 23:3131-3138.
35. Meis, J. F., G. Pool, G. J. van Gemert, A. H. Lensen, T. Ponnudurai, and J. H. Meuwissen. 1989. Plasmodium falciparum ookinetes migrate intercellularly through Anopheles stephensi midgut epithelium. Parasitol. Res. 76: 13-19.
36. Paton, M. G., G. C. Barker, H. Matsuoka, J. Ramesar, C. J. Janse, A. P. Waters, and R. E. Sinden. 1993. Structure and expression of a post-transcriptionally regulated malaria gene encoding a surface protein from the sexual stages of Plasmodium berghei. Mol. Biochem. Parasitol. 59:263-275.
37. Qian, F., Y. Wu, O. Muratova, H. Zhou, G. Dobrescu, P. Duggan, L. Lynn, G. Song, Y. L. Zhang, K. Reiter, N. MacDonald, D. L. Narum, C. A. Long, L. H. Miller, A. Saul, and G. E. D. Mullen. 2007. Conjugating recombinant proteins to Pseudomonas aeruginosa exoprotein A: a strategy for enhancing immunogenicity of malaria vaccine candidates. Vaccine 25:3923-3933.
38. Rawlings, D. J., and D. C. Kaslow. 1992. Adjuvant-dependent immune response to malarial transmission-blocking vaccine candidate antigens. J. Exp. Med. 176:1483-1487.
39. Read, D., A. H. Lensen, S. Begarnie, S. Haley, A. Raza, and R. Carter. 1994. Transmission-blocking antibodies against multiple, non-variant target epitopes of the Plasmodium falciparum gamete surface antigen Pfs230 are all complement-fixing. Parasite Immunol. 16:511-519.
40. Rener, J., P. M. Graves, R. Carter, J. L. Williams, and T. R. Burkot. 1983. Target antigens of transmission-blocking immunity on gametes of Plasmodium falciparum. J. Exp. Med. 158:976-981.
41. Sauerwein, R. W., and W. M. Eling. 2002. Sexual and sporogonic stage antigens. Chem. Immunol. 80:188-203.
42. Saxena, A. K., K. Singh, H. P. Su, M. M. Klein, A. W. Stowers, A. J. Saul, C. A. Long, and D. N. Garboczi. 2006. The essential mosquito-stage P25 and P28 proteins from Plasmodium form tile-like triangular prisms. Nat. Struct. Mol. Biol. 13:90-91.
43. Shahabuddin, M., T. Toyoshima, M. Aikawa, and D. C. Kaslow. 1993. Transmission-blocking activity of a chitinase inhibitor and activation of malarial parasite chitinase by mosquito protease. Proc. Natl. Acad. Sci. USA 90:4266-4270.
44. Shi, Y. P., M. P. Alpers, M. M. Povoa, and A. A. Lai. 1992. Single amino acid variation in the ookinete vaccine antigen from field isolates of Plasmodium falciparum. Mol. Biochem. Parasitol. 50:179-180.
45. Siden-Kiamos, I., and C. Louis. 2004. Interactions between malaria parasites and their mosquito hosts in the midgut. Insect Biochem. Mol. Biol. 34:679-685.
46. Siden-Kiamos, I., D. Vlachou, G. Margos, A. Beetsma, A. P. Waters, R. E. Sinden, and C. Louis. 2000. Distinct roles for pbs21 and pbs25 in the in vitro ookinete to oocyst transformation of Plasmodium berghei. J. Cell Sci. 113: 3419-3426.
47. Sieber, K. P., M. Huber, D. Kaslow, S. M. Banks, M. Torii, M. Aikawa, and L. H. Miller. 1991. The peritrophic membrane as a barrier: its penetration by Plasmodium gallinaceum and the effect of a monoclonal antibody to ookinetes. Exp. Parasitol. 72:145-156.
48. Sinden, R. E., L. Winger, E. H. Carter, R. H. Hartley, N. Tirawanchai, C. S. Davies, J. Moore, and J. F. Sluiters. 1987. Ookinete antigens of Plasmodium berghei: a light and electron-microscope immunogold study of expression of the 21 kDa determinant recognized by a transmission-blocking antibody. Proc. R. Soc. Lond. B 230:443-458.
49. Snow, R. W., M. Craig, U. Deichmann, and K. Marsh. 1999. Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. Bull. W. H. O. 77:624-640.
50. Spano, F., H. Matsuoka, R. Ozawa, Y. Chinzei, and R. E. Sinden. 1996. Epitope mapping on the ookinete surface antigen Pbs21 of Plasmodium berghei: identification of the site of binding of transmission-blocking monoclonal antibody 13.1. Parassitologia 38:559-563.
51. Stowers, A. W., D. B. Keister, O. Muratova, and D. C. Kaslow. 2000. A region of Plasmodium falciparum antigen Pfs25 that is the target of highly potent transmission-blocking antibodies. Infect. Immun. 68:5530-5538.
52. Stura, E. A., A. C. Satterthwait, J. C. Calvo, R. S. Stefanko, J. P. Langeveld, and D. C. Kaslow. 1994. Crystallization of an intact monoclonal antibody (4B7) against Plasmodium falciparum malaria with peptides from the Pfs25 protein antigen. Acta Crystallogr. D 50:556-562.
53. Tachibana, M., T. Tsuboi, T. J. Templeton, O. Kaneko, and M. Torii. 2001. Presence of three distinct ookinete surface protein genes, Pos25, Pos28-1, and Pos;28-2, in Plasmodium ovale. Mol. Biochem. Parasitol. 113:341-344.
54. Templeton, T. J., and D. C. Kaslow. 1999. Identification of additional members define a Plasmodium falciparum gene superfamily which includes Pfs48/45 and Pfs230. Mol. Biochem. Parasitol. 101:223-227.
55. Templeton, T. J., D. C. Kaslow, and D. A. Fidock. 2000. Developmental arrest of the human malaria parasite Plasmodium falciparum within the mosquito midgut via CTRP gene disruption. Mol. Microbiol. 36:1-9.
56. Tomas, A. M., G. Margos, G. Dimopoulos, L. H. van Lin, T. F. de Koning-Ward, R. Sinha, P. Lupetti, A. L. Beetsma, M. C. Rodriguez, M. Karras, A. Hager, J. Mendoza, G. A. Butcher, F. Kafatos, C. J. Janse, A. P. Waters, and R. E. Sinden. 2001. P25 and P28 proteins of the malaria ookinete surface have multiple and partially redundant functions. EMBO J. 20:3975-3983.
57. Tsai, Y. L., R. E. Hayward, R. C. Langer, D. A. Fidock, and J. M. Vinetz. 2001. Disruption of Plasmodium falciparum chitinase markedly impairs parasite invasion of mosquito midgut. Infect. Immun. 69:4048-4054.
58. Tsuboi, T., Y. M. Cao, D. C. Kaslow, K. Shiwaku, and M. Torii. 1997. Primary structure of a novel ookinete surface protein from Plasmodium berghei. Mol. Biochem. Parasitol. 85:131-134.
59. Tsuboi, T., D. C. Kaslow, Y. M. Cao, K. Shiwaku, and M. Torii. 1997. Comparison of Plasmodium yoelii ookinete surface antigens with human and avian malaria parasite homologues reveals two highly conserved regions. Mol. Biochem. Parasitol. 87:107-111.
60. Tsuboi, T., D. C. Kaslow, M. M. Gozar, M. Tachibana, Y. M. Cao, and M. Torii. 1998. Sequence polymorphism in two novel Plasmodium vivax ookinete surface proteins, Pvs25 and Pvs28, that are malaria transmission-blocking vaccine candidates. Mol. Med. 4:772-782.
61. Tsuboi, T., M. Tachibana, O. Kaneko, and M. Torii. 2003. Transmission-blocking vaccine of vivax malaria. Parasitol. Int. 52:1-11.
62. van Amerongen, A., R. W. Sauerwein, P. J. Beckers, R. H. Meloen, and J. H. Meuwissen. 1989. Identification of a peptide sequence of the 25 kD surface protein of Plasmodium falciparum recognized by transmission-blocking monoclonal antibodies: implications for synthetic vaccine development. Parasite Immunol. 11:425-428.
63. Vermeulen, A. N., T. Ponnudurai, P. J. Beckers, J. P. Verhave, M. A. Smits, and J. H. Meuwissen. 1985. Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission- blocking antibodies in the mosquito. J. Exp. Med. 162:1460-1476.
64. Vlachou, D., G. Lycett, I. Siden-Kiamos, C. Blass, R. E. Sinden, and C. Louis. 2001. Anopheles gambiae laminin interacts with the P25 surface protein of Plasmodium berghei ookinetes. Mol. Biochem. Parasitol. 112:229-237.
65. Vlachou, D., T. Zimmermann, R. Cantera, C. J. Janse, A. P. Waters, and F. C. Kafatos. 2004. Real-time, in vivo analysis of malaria ookinete locomotion and mosquito midgut invasion. Cell. Microbiol. 6:671-685.
66. r 21 kD determinant identified by transmission-blocking monoclonal antibodies. Parasite Immunol. 10:193-207.
67. Wu, Y., C. Przysiecki, E. Flanagan, S. N. Bello-Irizarry, R. Ionescu, O. Muratova, G. Dobrescu, L. Lambert, D. Keister, Y. Rippeon, C. A. Long, L. Shi, M. Caulfield, A. Shaw, A. Saul, J. Shiver, and L. H. Miller. 2006. Sustained high-titer antibody responses induced by conjugating a malarial vaccine candidate to outer-membrane protein complex. Proc. Natl. Acad. Sci. USA 103:18243-18248.
68. Yoeli, M., and R. S. Upmanis. 1968. Plasmodium berghei ookinete formation in vitro. Exp. Parasitol. 22:122-128.
69. Yuda, M., H. Sakaida, and Y. Chinzei. 1999. Targeted disruption of the Plasmodium berghei CTRP gene reveals its essential role in malaria infection of the vector mosquito. J. Exp. Med. 190:1711-1716.
70. Yuda, M., K. Yano, T. Tsuboi, M. Torii, and Y. Chinzei. 2001. von Willebrand factor A domain-related protein, a novel microneme protein of the malaria ookinete highly conserved throughout Plasmodium parasites. Mol. Biochem. Parasitol. 116:65-72.
71. Zieler, H., and J. A. Dvorak. 2000. Invasion in vitro of mosquito midgut cells by the malaria parasite proceeds by a conserved mechanism and results in death of the invaded midgut cells. Proc. Natl. Acad. Sci. USA 97:11516-11521.
72. Zollner, G. E., N. Ponsa, R. E. Coleman, J. Sattabongkot, and J. A. Vaughan. 2005. Evaluation of procedures to determine absolute density of Plasmodium vivax ookinetes. J. Parasitol. 91:453-457.
73. Zou, L., A. P. Miles, J. Wang, and A. W. Stowers. 2003. Expression of malaria transmission-blocking vaccine antigen Pfs25 in Pichia pastoris for use in human clinical trials. Vaccine 21:1650-1657.